Latest News
SpaceX's $2 Trillion Valuation Faces Key CFO Test This Thursday
SpaceX shares hit $153.47, pushing market cap to $2.02 trillion. All eyes on CFO Bret Johnsen's Thursday remarks to justify the lofty valuation amid heavy AI and infrastructure spending.
Rocket Lab's New Solar Cell: Supply Chain Win, Valuation Questions Remain
Rocket Lab's new solar cell solves a supply chain problem but not its valuation. Shares rose 2.5% as the company unveiled IMM Apex.
ZEC Surges 44% in a Week—What the NU7 Vote Really Means
Zcash's ZEC token surged 44% in a week, but the upcoming NU7 vote won't change total supply. Here's what it actually decides.
RBA September Hike Odds at 74%: Why the Market Could Still Be Surprised
Markets see a 74% probability of an RBA rate hike on September 29, but Deputy Governor Hauser cautions the decision isn't set in stone. Key data and oil prices could shift the outcome.
UK's Apple Child-Safety Law: What It Means for AAPL Investors
Britain is set to introduce primary legislation mandating device-level protections against child sexual abuse imagery. Apple faces potential precedent-setting rules that could affect its privacy stance and iOS design.
Vietjet's $199 Australia Fare: A Test of Pricing Power
Vietjet shares rose 0.8% after launching AUD199 Australia fares, but the real story is the airline's thin 1.1% quarterly margin and its test of pricing power in a growing international network.
MARA Rises 4.6% Despite Bitcoin Dip: Valuation Breakdown
MARA stock rose 4.6% to $11.83 despite Bitcoin slipping 0.9%. Valuation gap highlights $1.78B beyond Bitcoin holdings, with debt and pledged coins in play.
American Airlines' Unhedged Fuel Risk Exposed as Brent Nears $100
Brent crude's surge toward $100 intensifies pressure on American Airlines (AAL), which remains unhedged. A 10-cent per gallon change can swing quarterly fuel costs by ~$121 million.
Nvidia's 2% Dip Tests $108B Revenue Target as Chip Rally Diverges
Nvidia shares fell 2% even as the chip sector rallied. Investors weigh the $108B revenue target against valuation and margin concerns.
PDS Biotech Soars 36% on $22.55M Financing: Dilution Concerns Loom
PDS Biotechnology (PDSB) surged 36% after announcing a $22.55 million PIPE led by Nant Capital, but the deal involves significant dilution. Here's the breakdown.
ATAI Stock Holds at $7.28 as Lilly Deal Nears Close; CVR Value Priced at 53 Cents
ATAI shares closed at $7.28 after shareholders approved Eli Lilly's takeover. The market values the contingent value right at 53 cents, a fraction of its $2.50 maximum.